Split compensation

[Anonymous]

I have been reading a very long and informative thread which discussed in part, compensation/bonus. The poster was saying if your territory uncovers a patient and that patient needs to be treated out of your territory, you do not receive the bonus monies for that patient. And when the patient comes back to your territory, you are responsible for the follow up...or something like that. So. If this is true: a patient starts in Territory A then transfers to Territory B for treatment, then back to Territory A.....why can't the commission on that patient be split 50/50?

 

[Anonymous]

Because dividing by 2 is so very hard for us to do in HQ.

 

[Anonymous]

To OP: that has been a big issue for years for those of us in the field. Especially, if your territory has no real treatment centers (lack of facility resources/specialists for pheresis, small practice hesitation at working with such an expensive drug with a company that has a strict no return policy regardless of situation even if the patient does not show/transfers to different practice/expires, or transfers to a "big"/academic institution because their physician has no experience in the disease and they want a specialist who has (think "life threatening condition with their loved one/child")
The rep w the territory where the "drug goes in the vein" gets the start credit for quota and payout. When the patient returns home for treatment (every 2 weeks, forever), the original referring territory is responsible for maintaining the patient on treatment.
Problem is the "less expert" MD still has concerns, often isn't convinced the patient needs the $$$$$ therapy, and lets the patient stop (other reasons, too) Then the original rep gets "hit" for the lack of retention. And never even got paid on the patient start.
It makes a huge difference to that rep especially because there are so few patients in existence, and there isn't consistent clinical agreement that either indication needs to be treated chronically